Visomitin Attenuates Pathological Bone Loss by Reprogramming Osteoclast Metabolism via the STAT3/LDHB Axis
1Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
2Zhejiang Key Laboratory of Mechanism Research and Precision Repair of Orthopaedic Trauma and Aging Diseases, Hangzhou, China.
3Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China.
4Movement System lnjury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, China.
5Department of Orthopedics Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
6Department of Orthopaedics, Tongde Hospital of Zhejiang Province, Hangzhou, China.
收起